Menu
Log In
Search for
Switch skin
Home
About Us
News
Local Dynamics
Global Trends
M&A
Solutions
Business Consulting
Recruitment Solutions
Capability Development
Corporate Wellness
Careers
Videos
Executive Insights
Strategic Trends
Capability Growth
Corporate Wellness
Knowledge
Executive Insights
Strategic Trends
Human Resources
Capability Growth
Corporate Wellness
Regulations
Import & Export
Tax & Pricing
Labor & Salary
Pharmaceutical Compliance
Newsletter
Events
Contact
Contact Us
FAQS
Saturday, December 20 2025
Breaking News
Biotech Acquirer Xoma to Acquire Generation Bio
Sanofi Secures Deals for Novel Alzheimer’s Drug and Next-Generation Autoimmune Therapy
Major Pharmaceutical Company Lowers Revenue Forecast, Shares Drop
New Biotech Startup Secures $125 Million to Advance Pain Medication
Launch of Healthcare Technology Innovation Center by Pharmaceutical Giant and University
Health Ministry Mandates Stricter Enforcement Against Drug and Cosmetic Violations
Biopharma Firm Finalizes Takeover of French Immuno-Oncology Specialist
Pharmaceutical Company Declares Highest-Ever Cash Dividend Payout
Vietnamese Healthcare Facility Deploys New Generation Diagnostic Imaging Equipment
Sanofi Signs Potential $1 Billion Deal for Alzheimer’s Antibody Asset
Facebook
LinkedIn
Log In
Random Article
Switch skin
Home
/
Global Trends
Global Trends
Biotech Acquirer Xoma to Acquire Generation Bio
3 days ago
Biotech Acquirer Xoma to Acquire Generation Bio
Sanofi Secures Deals for Novel Alzheimer’s Drug and Next-Generation Autoimmune Therapy
3 days ago
Sanofi Secures Deals for Novel Alzheimer’s Drug and Next-Generation Autoimmune Therapy
Major Pharmaceutical Company Lowers Revenue Forecast, Shares Drop
3 days ago
Major Pharmaceutical Company Lowers Revenue Forecast, Shares Drop
New Biotech Startup Secures $125 Million to Advance Pain Medication
3 days ago
New Biotech Startup Secures $125 Million to Advance Pain Medication
Sanofi Signs Potential $1 Billion Deal for Alzheimer’s Antibody Asset
4 days ago
Sanofi Signs Potential $1 Billion Deal for Alzheimer’s Antibody Asset
Alphyn Biologics Secures $25 Million in Series B Funding
4 days ago
Alphyn Biologics Secures $25 Million in Series B Funding
SOBI Agrees to Acquire Arthrosi Therapeutics
4 days ago
SOBI Agrees to Acquire Arthrosi Therapeutics
Strategic Partnership Expanded Between Dren Bio and Sanofi for Next-Generation B-Cell Therapy
4 days ago
Strategic Partnership Expanded Between Dren Bio and Sanofi for Next-Generation B-Cell Therapy
PARP Combination Therapy Expands Treatment Indication in Prostate Cancer
4 days ago
PARP Combination Therapy Expands Treatment Indication in Prostate Cancer
J&J Multiple Myeloma Drug Regimen Receives Proactive National Priority Review Voucher from the FDA
4 days ago
J&J Multiple Myeloma Drug Regimen Receives Proactive National Priority Review Voucher from the FDA
Novel Combination Therapy Gains Initial Approval for Metastatic Breast Cancer Treatment
4 days ago
Novel Combination Therapy Gains Initial Approval for Metastatic Breast Cancer Treatment
National Occupational Health Provider Extends Reach in Florida
4 days ago
National Occupational Health Provider Extends Reach in Florida
Strategic Collaboration Signed to Advance Metabolic Disorder Treatments
6 days ago
Strategic Collaboration Signed to Advance Metabolic Disorder Treatments
China’s NMPA Clears Two Sanofi Treatments for Rare Hematologic Diseases
6 days ago
China’s NMPA Clears Two Sanofi Treatments for Rare Hematologic Diseases
European Union Advances New Pharmaceutical Regulatory Framework
6 days ago
European Union Advances New Pharmaceutical Regulatory Framework
Novel Monoclonal Antibody Gains FDA Clearance for Generalized Myasthenia Gravis
6 days ago
Novel Monoclonal Antibody Gains FDA Clearance for Generalized Myasthenia Gravis
Regulator Authorizes New Oral Antibiotic Option for Gonorrhea
6 days ago
Regulator Authorizes New Oral Antibiotic Option for Gonorrhea
Pharmaceutical Corporation Breaks Ground on Flagship US Production Center in North Carolina
1 week ago
Pharmaceutical Corporation Breaks Ground on Flagship US Production Center in North Carolina
Zydus Lifesciences and Formycon Partner to Supply Keytruda® Biosimilar for Cancer Patients in US and Canada
1 week ago
Zydus Lifesciences and Formycon Partner to Supply Keytruda® Biosimilar for Cancer Patients in US and Canada
Novartis and UK Biotech Relation Announce R&D Collaboration
1 week ago
Novartis and UK Biotech Relation Announce R&D Collaboration
Load More
Back to top button
Close
Close
Log In
Forget?
Remember me
Log In
Don't have an account?